Cost-Effectiveness of Pembrolizumab as First-Line Therapy for Advanced Colorectal Cancer With High Microsatellite Instability or Mismatched Repair Deficiency in Japan. - Taniguchi S; Moriwaki K; Morimoto K; Shimozuma K (Value in health regional issues, 2025)